|Slideshows|August 10, 2018

5 Reports on Depression

This special collection provides new insights on major aspects of depression: psychopharmacology, therapeutic interventions, major depressive episodes, biomarkers, and pseudobulbar affect.

Newsletter

Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.

Subscribe Now!

Related Content

FDA Clears Investigational New Drug Application for TNX-102 SL for Treatment of Major Depressive Disorder

ByJessica Walters

November 24th 2025

transcranial magnetic stimulation depression treatment

Use of TMS in Treatment of Depression, Discussion With Rachel Rohaidy, MD

ByRachel Rohaidy, MD

November 24th 2025

Glutamatergic Pathways in Major Depressive Disorder: Insights From Juan D. Oms, MD, FAPA

ByJuan D. Oms, MD, FAPA

November 22nd 2025

Vagus Nerve Stimulation in Treatment Resistant Depression: New Lines of Thinking

ByLeah Kuntz

November 22nd 2025

Novel Therapeutic Targets for Major Depressive Disorder: In Conversation With Ginger Shupe, MD

ByGinger Shupe, MD

November 22nd 2025

5 Reports on Depression

Newsletter

Related Content

FDA Clears Investigational New Drug Application for TNX-102 SL for Treatment of Major Depressive Disorder

Use of TMS in Treatment of Depression, Discussion With Rachel Rohaidy, MD

Glutamatergic Pathways in Major Depressive Disorder: Insights From Juan D. Oms, MD, FAPA

Vagus Nerve Stimulation in Treatment Resistant Depression: New Lines of Thinking

Novel Therapeutic Targets for Major Depressive Disorder: In Conversation With Ginger Shupe, MD

Trending on Psychiatric Times

The Hybrid Model: Humans & Chatbots Working Together

Interrelation of Hormones and Adult ADHD

The Truth About Insomnia and Melatonin: Natural Does Not Always Mean Harmless

Through the Peaks and Valleys: Assessing and Addressing Suicide Risk in Bipolar Disorder

Lithium Reduces Risk of Suicide and Recurrent Episodes of Bipolar and Major Depressive Disorders